MedPath

Safety and Efficacy Study of Fabulous Stent Graft System for Stanford B Aortic Dissection

Not Applicable
Completed
Conditions
Aortic Dissection Type B
Interventions
Device: Fabulous Stent Graft System
Registration Number
NCT04918212
Lead Sponsor
Hangzhou Endonom Medtech Co., Ltd.
Brief Summary

A prospective, multi-center, objective performance criteria clinical trial to evaluate the safety and efficacy of Fabulous Stent Graft System manufactured by Hangzhou Endonom Medtech Co., Ltd. for Stanford B Aortic Dissection.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
148
Inclusion Criteria
  1. Patients ≥18 years old;
  2. The informed consent was signed by the patient or the legal representative;
  3. Diagnosed with Stanford B aortic dissection;
  4. The proximal anchoring area of is 18-42 mm in diameter, and not less than 15mm in length;
  5. Has a suitable arterial approach and is suitable for surgical treatment.
Exclusion Criteria
  1. The patient's distal vascular false cavity has been completely thrombotic or organized;
  2. Pregnant or breastfeeding ;
  3. Has participated in clinical trials of other devices ;
  4. History of aortic surgery or endovascular repair surgery ;
  5. Allergic to contrast agents and anesthetics ;
  6. Allergic to stents or conveyors ;
  7. Patients with true or false aortic aneurysm;
  8. History of myocardial infarction, TIA or cerebral infarction within the past 3 months;
  9. Life expectancy is less than 12 months;
  10. Other situations in which the investigator judges that not suitable for endovascular treatment .

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Fabulous Stent Graft SystemFabulous Stent Graft SystemAll patients received endovascular surgery using fabulous stent graft system
Primary Outcome Measures
NameTimeMethod
Number of patients with no incidence of major surgical or device related adverse events ratewithin 30 days after surgery

Surgical or device related major adverse events (MAE) : death, respiratory failure, renal failure, stroke, paraplegia, intestinal ischemia, cardiovascular and vascular complications caused by surgery or device

Clinical success rate12 months after surgery

Clinical success is defined as : no displacement of Stent Graft System, no type I or III endoleak requiring treatment, no enlargement of the false lumen, thrombosis of the false lumen, and no rupture of the dissection

Secondary Outcome Measures
NameTimeMethod
Endoleak ratewithin 12 months after surgery
adverse event ratewithin 12 months after surgery
Immediate operation successful rateimmediately after the surgery

After the operation, angiographic observation showed that the proximal covered stent was in an appropriate position and adhered well without obvious endoleak, while the distal bare stent was in an appropriate position and adhered well

Immediate delivery success rateimmediately after the surgery

The stent graft system was successfully transported to the correct position and released successfully

Secondary surgical treatment ratewithin 12 months after surgery

Secondary endovascular or surgical treatment due to stent displacement, endoleak, or related complications after stent implantation

Trial Locations

Locations (24)

West China Hospital of Sichuan University

🇨🇳

Chengdu, China

Chinese People's Liberation Army General Hospital

🇨🇳

Beijing, China

Peking University People's Hospital

🇨🇳

Beijing, China

The First Affiliated Hospital of Fujian Medical University

🇨🇳

Fuzhou, China

Hainan Provincial People's Hospital

🇨🇳

Haikou, China

The First Affiliated Hospital of Zhejiang University School of Medicine

🇨🇳

Hangzhou, China

Anhui Provincial Hospital

🇨🇳

Hefei, China

The First Affiliated Hospital of Kunming Medical College

🇨🇳

Kunming, China

Liuzhou Workers' Hospital

🇨🇳

Liuzhou, China

The Second Affiliated Hospital of Nanchang University

🇨🇳

Nanchang, China

The First Affiliated Hospital of Guangxi Medical University

🇨🇳

Nanning, China

The Ninth People's Hospital Affiliated to Shanghai Jiaotong University School of Medicine

🇨🇳

Shanghai, China

Jiangsu Provincial People's Hospital

🇨🇳

Nanjing, China

Zhongshan Hospital Affiliated to Fudan University

🇨🇳

Shanghai, China

The First Hospital of Hebei Medical University

🇨🇳

Shijia Zhuang, China

Tianjin Medical University General Hospital

🇨🇳

Tianjin, China

The First Affiliated Hospital of the Fourth Military Medical University

🇨🇳

Xi'an, China

First Affiliated Hospital of Zhengzhou University

🇨🇳

Zhengzhou, China

Henan Provincial People's Hospital

🇨🇳

Zhengzhou, China

Beijing Friendship Hospital, Capital Medical University

🇨🇳

Beijing, China

Xiangya Hospital of Central South University

🇨🇳

Changsha, China

Guangdong Provincial People's Hospital

🇨🇳

Guangzhou, China

Second Affiliated Hospital of Zhejiang University School of Medicine

🇨🇳

Hangzhou, China

Yantai Yuhuangding Hospital

🇨🇳

Yantai, China

© Copyright 2025. All Rights Reserved by MedPath